Machine Learning: A New Approach for Dose Individualization

Abstract

The application of machine learning (ML) has shown promising results in precision medicine due to its exceptional performance in dealing with complex multidimensional data. However, using ML for individualized dosing of medicines is still in its early stage, meriting further exploration. A systematic review of study designs and modeling details of using ML for individualized dosing of different drugs was performed. We have summarized the status of the study populations, predictive targets, and data sources for ML modeling, the selection of ML algorithms and features, and the evaluation and validation of their predictive performance. We also used the Prediction model Risk of Bias Assessment Tool (PROBAST) to assess the risk of bias of included studies. Currently, ML can be used for both a priori and a posteriori dose selection and optimization, and it can also assist the implementation of therapeutic drug monitoring. However, studies are mainly focused on drugs with narrow therapeutic windows, predominantly immunosuppressants (N=23, 35.9%) and anti‐infectives (N=21, 32.8%), and there is currently only very limited attention for special populations such as children (N=22, 34.4%). Most studies showed poor methodological quality and a high risk of bias. The lack of external validation and clinical utility evaluation currently limits the further clinical implementation of ML for dose individualization. We therefore have proposed several ways to improve the clinical relevance of the studies and facilitate the translation of ML models into clinical practice.

Optimal use of β-lactams in neonates: machine learning-based clinical decision support system

“…A theoretical approach is to simulate datasets, build ML models based on these simulations, and validate them using external data. 50 …”

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine

“…The authors reviewed the current research on AI bias, including its sources, and the methods used for its measurement, benchmarking, and mitigation, with a focus on the healthcare field and regulatory science. Li et al 24 . conducted a systematic review of the application of ML for dose individualization.…”

The Healthy Brain Initiative (HBI): A prospective cohort study protocol

“…Precision medicine is a model that permits the separation of patients into different groups to better inform and tailor medical decisions, practice, and treatment to defined subgroups based on their (a) predicted responses and/or (b) risk of disease [102][103][104]. Precision medicine approaches can help shift medical practice from reaction to prevention, predict susceptibility, improve early detection, and eliminate trial and error treatment thereby avoiding or limited negative side effects and maximizing efficacy [105]. Commonly used in oncology, precision medicine has expanded to other fields.…”